Abstract
Insomnia is often associated with substance dependence, with evidence suggesting that individuals seeking medical attention for sleep complaints are more likely to have drug or alcohol abuse problems than the general population. Disturbed sleep is associated with the abuse of a variety of drugs, with patients dependent on nicotine, alcohol and illicit drugs all reporting poor sleep. In addition, withdrawal from nicotine, alcohol and drugs of abuse is also associated with insomnia, and this may result in an increased risk of relapse if the sleep problems remain unresolved. Although studies suggest that the majority of pharmacological and behavioural interventions for insomnia are effective in treating sleep disturbances in dependent patients undergoing short-term drug withdrawal and short and long-term alcohol withdrawal, several questions remain unanswered. For example, little is known about the risk of relapse in abstinent drug-dependent patients experiencing withdrawal-related insomnia, the effect of insomnia treatment on nicotine withdrawal, or whether insomnia interventions prevent relapse. Participants of a workshop, held at the 6th annual meeting of The International Sleep Disorders Forum: The Art of Good Sleep in 2008, evaluated whether the effective management of sleep disorders could reduce substance dependence and the risk of relapse. Following the workshop a targeted literature review was conducted addressing this question. Data from this review that either pharmacological or cognitive behavioural treatment of insomnia could reduce the risk of relapse in substance dependence were substantially lacking. Further research is therefore required to increase our understanding of the impact of insomnia on patients with substance dependence.
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington (D.C.): American Psychiatric Press, 1994; 886 pp
Passarella S, Duong MT. Diagnosis and treatment of insomnia. Am J Health Syst Pharm 2008; 65: 927–34
Teplin D, Raz B, Daiter J, et al. Screening for substance use patterns among patients referred for a variety of sleep complaints. Am J Drug Alcohol Abuse 2006; 32: 111–20
Foulds J, Gandhi KK, Steinberg MB, et al. Factors associated with quitting smoking at a tobacco dependence treatment clinic. Am J Health Behav 2006; 30: 400–12
Bover MT, Foulds J, Steinberg MB, et al. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome. Int J Clin Pract 2008; 62: 182–90
Scharf DM, Dunbar MS, Shiffman S. Smoking during the night: prevalence and smoker characteristics. Nicotine Tobacco Res 2008; 10: 167–78
Montgomery C, Fisk JE, Wareing M, et al. Self reported sleep quality and cognitive performance in ecstasy users. Human Psychopharmacol 2007; 22: 537–48
Crum RM, Ford DE, Storr CL, et al. Association of sleep disturbance with chronicity and remission of alcohol dependence: data from a population-based prospective study. Alcoholism: Clin Exp Res 2004; 28: 1533–40
Shinba T, Murashima YL, Yamamoto K. Alcohol consumption and insomnia in a sample of Japanese alcoholics. Addiction 1994; 89: 587–91
Foster JH, Peters TJ. Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome. Alcohol Clin Exp Res 1999; 23: 1044–51
Currie SR, Clark S, Rimac S, et al. Comprehensive assessment of insomnia in recovering alcoholics using daily sleep diaries and ambulatory monitoring. Alcohol Clin Exp Res 2003; 27: 1262–9
Conroy DA, Todd Arnedt J, Brower KJ, et al. Perception of sleep in recovering alcohol-dependent patients with insomnia: relationship with future drinking. [erratum appears in Alcohol Clin Exp Res 2007; 31: 907]. Alcohol Clin Exp Res 2006; 30: 1992–9
Mello NK, Mendelson JH. Behavioral studies of sleep patterns in alcoholics during intoxication and withdrawal. J Pharmacol Exp Ther 1970; 175: 94–112
Irwin M, Gillin JC, Dang J, et al. Sleep deprivation as a probe of homeostatic sleep regulation in primary alcoholics. Biol Psychiatry 2002; 51: 632–41
Waldrop AE, Back SE, Sensenig A, et al. Sleep disturbances associated with posttraumatic stress disorder and alcohol dependence. Addict Behav 2008; 33: 328–35
Moreno-Coutino A, Calderon-Ezquerro C, Drucker-Colin R. Long-term changes in sleep and depressive symptoms of smokers in abstinence. Nicotine Tobacco Res 2007; 9: 389–96
Aubin HJ, Luthringer R, Demazieres A, et al. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep. Nicotine Tobacco Res 2006; 8: 193–201
Bolla KI, Lesage SR, Gamaldo CE, et al. Sleep disturbance in heavy marijuana users. Sleep 2008; 31: 901–8
Pace-Schott EF, Stickgold R, Muzur A, et al. Sleep quality deteriorates over a binge-abstinence cycle in chronic smoked cocaine users. Psychopharmacology (Berl) 2005; 179: 873–83
Oyefeso A, Sedgwick P, Ghodse H. Subjective sleep-wake parameters in treatment-seeking opiate addicts. Drug Alcohol Depend 1997; 48: 9–16
Peles E, Schreiber S, Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend 2006; 82: 103–10
Burke CK, Peirce JM, Kidorf MS, et al. Sleep problems reported by patients entering opioid agonist treatment. J Subst Abuse Treat 2008; 35: 328–33
Le Bon O, Verbanck P, Hoffmann G, et al. Sleep in detoxified alcoholics: impairment of most standard sleep parameters and increased risk for sleep apnea, but not for myoclonias — a controlled study. J Studies Alcohol 1997; 58: 30–6
Drummond SPA, Gillin JC, Smith TL, et al. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res 1998; 22: 1796–802
Brower KJ, Aldrich MS, Robinson EA, et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry 2001; 158: 399–404
Roehrs T, Hollebeek E, Drake C, et al. Substance use for insomnia in Metropolitan Detroit. J Psychosom Res 2002; 53: 571–6
Kaneita Y, Uchiyama M, Takemura S, et al. Use of alcohol and hypnotic medication as aids to sleep among the Japanese general population. Sleep Med 2007; 8: 723–32
Gossop M, Bradley B. Insomnia among addicts during supervised withdrawal from opiates: a comparison of oral methadone and electrostimulation. Drug Alcohol Depend 1984; 13: 191–8
Srisurapanont M, Jarusuraisin N. Amitriptyline versus lorazepam in the treatment of opiate-withdrawal insomnia: a randomized double-blind study. Acta Psychiatrica Scand 1998; 97: 233–5
Maremmani I, Pani PP, Pacini M, et al. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat 2007; 33: 91–8
Peles E, Hetzroni T, Bar-Hamburger R, et al. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial. Addiction 2007; 102: 1947–53
Fabre Jr LF, Gainey A, Kemple S, et al. Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal. J Studies Alcohol 1977; 38: 2188–92
Asheychik R, Jackson T, Baker H, et al. The efficacy of L-tryptophan in the reduction of sleep disturbance and depressive state in alcoholic patients. J Studies Alcohol 1989; 50: 525–32
Ansoms S, Lebon O, Pelc I, et al. Zopiclone or lormetazepam in the treatment of insomnia and the effect on behavior and mood in patients during the postalcoholism withdrawal period. Curr Therap Res-Clin Exp 1991; 49: 54–64
Monti JM, Alterwain P, Estevez F, et al. The effects of ritanserin on mood and sleep in abstinent alcoholic patients. Sleep 1993; 16: 647–54
Aubin HJ, Goldenberg F, Tilikete S, et al. Carbamates and benzodiazepines have different effects on detoxified alcoholics’ sleep polygraphy. Human Psychopharmacol 1996; 11:205–10
Schmitz M, Frey R, Pichler P, et al. Sleep quality during alcohol withdrawal with bright light therapy. Progr Neuro-Psychopharmacol Biol Psychiatry 1997; 21: 965–77
Greeff AP, Conradie WS. Use of progressive relaxation training for chronic alcoholics with insomnia. Psychological Rep 1998; 82: 407–12
Wiesbeck GA, Weijers HG, Chick J, et al. The effects of ritanserin on mood, sleep, vigilance, clinical impression, and social functioning in alcohol-dependent individuals. Ritanserin in Alcoholism Work Group. Alcohol Alcoholism 2000; 35: 384–9
Malcolm R, Myrick H, Roberts J, et al. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict 2002; 11: 141–50
Karam-Hage M, Brower KJ. Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients. Psychiatry Clin Neurosci 2003; 57: 542–4
Le Bon O, Murphy JR, Staner L, et al. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol 2003; 23: 377–83
Currie SR, Clark S, Hodgins DC, et al. Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics. Addiction 2004; 99: 1121–32
Gann H, Feige B, Cloot O, et al. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients — aA double-blind and randomized study. Pharmacopsychiatry 2004; 37: 228–35
Arnedt JT, Conroy D, Rutt J, et al. An open trial of cognitive-behavioral treatment for insomnia comorbid with alcohol dependence. Sleep Med 2007; 8: 176–80
Brower KJ, Myra Kim H, Strobbe S, et al. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res 2008; 32: 1429–38
Friedmann PD, Rose JS, Swift R. Trazodone for sleep disturbances after alcohol detoxification: a double-blind, placebo-controlled trial. Alcohol Clin Exp Res 2008; 32: 1652–60
Watanabe KI, Ogihara-Hashizume A, Kobayashi Y, et al. Impaired sleep during the post-alcohol withdrawal period in alcoholic patients. Addict Biol 2001; 6: 163–9
Cohn TJ, Foster JH, Peters TJ. Sequential studies of sleep disturbance and quality of life in abstaining alcoholics. Addict Biol 2003; 8: 455–62
Currie SR, Malhotra S, Clark S. Agreement among subjective, objective, and collateral measures of insomnia in postwithdrawal recovering alcoholics. Behav Sleep Med 2004; 2: 148-61
Acknowledgements
The discussions that took place during a workshop at the 6th annual meeting of The International Sleep Disorders Forum: The Art of Good Sleep, held in 2008, contributed to the preparation of this article. The author would like to thank the following individuals who attended the workshop and contributed to the discussions that have informed the content of this article: James Ballenger (USA), Alan Bateson (UK), Edward Bixler (USA), Daniel Buysse (USA), Bruce Corser (USA), Kenneth Lichstein (USA), Teresa Paiva (Portugal), Sylvie Royant-Parola (France), Hardeep Singh (USA) and Bradley Vaughn (USA). The author would like to thank Sheridan Henness and Matt Weitz from Wolters Kluwer Pharma Solutions for providing medical writing support in the preparation of this article. This assistance was supported by sanofi-aventis. The International Sleep Disorders Forum: The Art of Good Sleep 2008 was funded by sanofi-aventis.
Declaration of conflicts of interest: Thomas Roth declares no conflicts of interest, and received no honoraria for the writing of this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roth, T. Does Effective Management of Sleep Disorders Reduce Substance Dependence?. Drugs 69 (Suppl 2), 65–75 (2009). https://doi.org/10.2165/11531120-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11531120-000000000-00000